NEW trial now opened by Birmingham University ... - CLL Support
NEW trial now opened by Birmingham University CLL specialists in UK to measure your response as CLL patients to the vaccine.
You need to be a member of this community to see this post.
Read more about...
31 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Living in the USA with CLL and want to know where to sign up for your COVID-19 Vaccination? A State-by-State List
From MedPage Today: Every state has posted information on its plan; many (though not all) list...
LLS Covid-19 Vaccine Trial: Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
Posted July 29, 2021 by Dr. Brian Koffman...
LLS Ciitizen USA Study Shows Most Blood Cancer Patients Benefit from an Additional (3rd) COVID-19 Vaccine Dose
The LLS National Patient Registry & The Leukemia & Lymphoma Society® (LLS) is a global leader in...
T-cell /Cellular Immune Responses in Patients with CLL from the Pfizer-BioNTech COVID-19 Vaccine (BNT162b mRNA Covid19 Vaccine)
From Dr Tamar Tadmor, Head of the Israeli CLL study group at iwCLL.
Patients with CLL suffer from...
Research shows blood cancer patients generate strong T cell immunity after SARS-CoV-2 vaccination
Today, the Doherty Institute in Melbourne, Australia, released a statement about a research study...
Related Posts
- Important SARS-CoV-2 and Covid-19 information for Chronic Lymphocytic Leukaemia/CLL patients
Breaking News! The AZD7442 PROVENT Phase III Prophylaxis Trial met its primary endpoint in preventing symptomatic COVID-19!- Leukemia & Lymphoma Society COVID-19 vaccine safety data is now available ; vaccine antibody data expected later in 2021
Towards personalised management of CLL? Ibrutinib study reveals new way to gauge patients’ response to treatment- Clinical Trials of Monoclonal antibodies AZD7442 against SARS=CoV-2 (COVID19) - majority of sites in UK and USA
